Andrea Baragetti Redefines the Dialogue Between Heart and Kidney at EAS Milan
Andrea Baragetti, Associate Professor of Pharmacology at University of Milan, posted on LinkedIn:
”On the frontline of cardiovascular innovation
In Milan, at the European Atherosclerosis Society Advanced Course on Non-Classical Risk Factors, I had the privilege to stand among brilliant scientists and clinicians united by a single mission – to challenge what’s known and redefine the limits of cardiovascular and metabolic medicine.
Gratitude to the organizers and the European Atherosclerosis Society (EAS) for the opportunity to contribute with a talk on upfront therapeutic perspectives on cardio-renal syndrome – a field where the heart and kidney engage in a silent but relentless dialogue, and where every new insight can shift the balance between failure and recovery.
Science is a weapon, innovation is a creed.”
Keep up with Hemostasis Today.
-
Aug 11, 2026, 13:53Steven Lubega: Why Are Healthy Newborns Born Poorly Equipped To Stop Bleeding?
-
Aug 11, 2026, 13:47Why Stroke Risk Changes During Pregnancy – International Journal of Stroke
-
Aug 11, 2026, 13:43Moyahabo Julius Rampya: Shaping the Future of Stroke Care in Africa
-
Aug 11, 2026, 13:34Brett Hoover: Plaque Burden May Be Key to Predicting MACE Risk
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC